GOODRX, INC.

Lobbying for GOODRX, INC.

Filing 1st Quarter - Report

1st Quarter (Jan 1 - Mar 31) 2026 · California · House · Senate · $370,000.00 expenses · posted Apr 20, 2026

Lobbying activity 2

Health Issues

-Issues regarding prescription drug pricing. -Issues regarding telehealth.

Consumer Issues/Safety/Products

Monitoring federal legislation and outreach to congressional offices.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.